Skip to content
Fast Logic Drive Base

The Zimbabwean Government Declines ‘One-Sided’ American Healthcare Assistance Agreement Because of Data Concerns

Medical aid illustration
The offered American financial assistance was aimed at initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has declined a major US healthcare agreement worth 367 million US dollars (£272m) spanning five years over Washington's insistence on sensitive data.

This move became public after a official document dated December was leaked, indicating that President Emmerson Mnangagwa felt the deal was "lopsided".

A government spokesperson later stated that the United States was demanding access to biological samples for scientific study and commercial purposes but refused to guarantee the resulting advantages from future vaccines.

"We are forced to start the difficult and regrettable task of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the United States had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has called for more negotiations to find a deal suitable to all parties so the nation's vital HIV programme can proceed.

Wider Background

This development comes after a comparable situation in Kenya, where a court suspended a related health funding agreement after legal challenges were filed about the safety of Kenyans' medical information.

Since resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

USAID had administered aid for the US government, but Trump claimed its spending was "inefficient" and his government was seeking government-to-government agreements to boost openness and responsibility.

Based on reports, 16 nations in Africa have to date signed these new agreements, representing more than $18.3bn in committed funds.

Details of the Rejected Agreement

This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this partnership would have delivered significant benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment via American-funded initiatives," Tremont added.

However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".

"Our nation was requested to provide its genetic material and health information over an extended period, with no corresponding promise of access to any medical innovations – like new medicines or tests – that might be developed from that shared data," he stated.

"In essence, our country would supply the raw materials for medical research with no certainty that the end products would be available to our citizens should a future pandemic arise."

National Interest and Global Health

He also pointed out that the US's withdrawal from the global health body and its push of one-on-one health agreements were disrupting structures already set up through the international organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to manage future pandemics.

"This system is intended to guarantee that when a country provides its information, the benefits – including medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to create them."

These objections over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We are open to continued discussions with our US partners on how future collaboration might be structured in a manner that respects the sovereignty and interests of both nations."

Health Experts Response

A leading public health body said it acknowledged the official position, but urged that negotiations should continue since much of the country's HIV programmes depended on international support.

"Where technical issues arise, including those relating to data governance or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," the group added.

The halted deal underscores the continuing challenges between receiving vital international aid and safeguarding local interests in an ever more data-driven world.

JR
About the author

James Reed

Automotive journalist and enthusiast with a passion for electric vehicles and sustainable mobility.

Fast Logic Drive Base

Type to search articles.